top of page
.png)
Onco-Summaries: Daily Oncology Updates at a Glance
12/03/2026 Aminex Therapeutics' AMXT 1501 received the FDA ODD for Glioma Aminex Therapeutics' AMXT 1501 received the FDA ODD for Glioma ( Ref ) The US FDA granted the orphan drug designation to Aminex Therapeutics' AMXT 1501 (polyamine transport inhibitor) + difluoromethylornithine for the treatment of malignant glioma, including diffuse intrinsic pontine glioma (DIPG). The Beat Childhood Cancer Research Consortium at Penn State College of Medicine, in partnership with Amine
Oncofocus Team
2 days ago1 min read
Cell and Gene Therapy Updates
May 3rd Week, 2025 ⭐ Regulatory Update 🎯 The US FDA granted the RMAT designation to BrainChild Bio ’s BCB-276 (an autologous, B7-H3...
Oncofocus Team
Jun 23, 20252 min read
Cell and Gene Therapy Updates
April 3rd & 4th, 2025 Regulatory Updates 🎯 The UK MHRA granted conditional marketing authorization for Autolus Therapeutics ’...
Oncofocus Team
Jun 20, 20252 min read
bottom of page